Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$33.36 - $45.71 $1.05 Million - $1.44 Million
-31,583 Reduced 45.74%
37,459 $1.32 Million
Q4 2022

Feb 13, 2023

BUY
$35.77 - $51.11 $1.75 Million - $2.5 Million
48,899 Added 242.76%
69,042 $3.16 Million
Q3 2022

Oct 26, 2022

BUY
$38.54 - $54.52 $776,311 - $1.1 Million
20,143 New
20,143 $976,000
Q4 2021

Feb 14, 2022

SELL
$34.35 - $46.38 $245,671 - $331,709
-7,152 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$18.54 - $35.74 $132,598 - $255,612
7,152 New
7,152 $256,000

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.62B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Mirabella Financial Services LLP Portfolio

Follow Mirabella Financial Services LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirabella Financial Services LLP, based on Form 13F filings with the SEC.

News

Stay updated on Mirabella Financial Services LLP with notifications on news.